New research finds link between telomere length and lung disease
Brigham Young University biologist Jonathan Alder has a startling secret he doesn't freely share: he knows when most of us are going to die.
Feb 4, 2015
0
15
Brigham Young University biologist Jonathan Alder has a startling secret he doesn't freely share: he knows when most of us are going to die.
Feb 4, 2015
0
15
People who have had an organ transplant or have autoimmune diseases are more likely to become ill. Research into a key cellular signaling system suggests this may be partly due to previously unknown effects of treatment drugs, ...
Jan 21, 2015
0
11
A new test can guide treatment for patients with graft versus host disease (GVHD), an often life-threatening complication of bone marrow and stem cell transplants, according to research from the University of Michigan published ...
Jan 13, 2015
0
4
A team of scientists from the University of Colorado School of Medicine has reported the breakthrough discovery of a process to expand production of stem cells used to treat cancer patients. These findings could have implications ...
Aug 29, 2014
0
0
(Medical Xpress)—Melbourne researchers have revealed the critical importance of highly specialised immune cells, called natural killer cells, in killing melanoma cells that have spread to the lungs. These natural killer ...
Aug 14, 2014
0
1
A new protein biomarker test platform developed by researchers at the University of Michigan and Indiana University promises to improve diagnostic testing. The test can accurately and simultaneously measure multiple proteins ...
Jul 16, 2014
0
0
Use of a lower intensity bone marrow transplantation method showed promising results among 30 patients (16-65 years of age) with severe sickle cell disease, according to a study in the July 2 issue of JAMA.
Jul 1, 2014
0
0
(Medical Xpress)—Cornell researchers have identified a type of immune system cell that prevents a patient's body from attacking donor cells after a bone marrow transplant, a condition called graft-versus-host disease (GVHD).
Jun 27, 2014
0
0
Stem cell therapies work as a complement to standard treatments, potentially cutting the number of deaths after a year, suggests evidence from the latest Cochrane review: Stem cell therapy for chronic ischaemic heart disease ...
Apr 29, 2014
0
0
New research looking at the success of clinical trials of stem cell therapy shows that trials appear to be more successful in studies where there are more discrepancies in the trial data.
Apr 28, 2014
0
0